Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report

Raweekarn Itsathitpaisarn; Nattavong Suksawad; Watsapol Wongwikrom; Jerasit Surintrspanont; Thana Thongsricome

doi:10.12659/AJCR.949913

07 December 2025 : Case report Thailand

Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report

Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Rare disease, Adverse events of drug therapy

Raweekarn Itsathitpaisarn^{BF 1}, Nattavong Suksawad^{F 2}, Watsapol Wongwikrom^{F 2}, Jerasit Surintrspanont

^{B 3,4}, Thana Thongsricome

^{AE 1,5*}

DOI: 10.12659/AJCR.949913

Am J Case Rep 2025; 26:e949913

Authors information Article notes Copyright and License information

Introduction Case Report Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Progression of kidney function in correlation with the dosage adjustment of anti-proteinuric and anti-diabetic medications. UACR – urine albumin creatinine ratio.

Back to the Article

Acute Kidney Injury from Mononuclear Cell-Predominated Interstitial Nephritis After Introduction of a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report

Your Privacy